Invitation to presentation of Bactiguard’s interim report for the second quarter on July 18, 2023
Bactiguard Holding AB (publ) publishes its interim report for the second quarter on Tuesday July 18, 2023 at 08:00 CEST.
In connection with this, Bactiguard will host an audiocast for investors, analysts and media at 11:00 CEST. Interim CEO Thomas von Koch will present the report and, together with Carin Jakobson, CFO, answer questions. The report and a presentation will be available at Bactiguard’s website www.bactiguard.com
To participate in the audiocast, please use this link:
www.bactiguard.com/report/q2-2023/
To participate only by conference call, please register on the link above.
Questions can be asked either in writing via the audiocast or orally if you attend the conference call.
For further information, please contact:
Nina Nornholm, Communication & IR Director +46 708 550 356
Carin Jakobson, CFO +46 70 965 16 65
About Bactiguard
Bactiguard is a global medtech company with a purpose to prevent infections. We provide safe, cost-effective, and easy-to-use infection prevention technology and solutions across five therapeutic areas – orthopedics, urology, intravascular/critical care, dental, and wound care.
Bactiguard’s unique technology is based on a thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s solutions are biocompatible and make a positive impact by decreasing patient suffering, saving lives and healthcare resources. The solutions also fight antimicrobial resistance, one of the most serious threats to global health and modern medicine.
Bactiguard operates through license partnerships with leading global medtech companies, such as BD and Zimmer Biomet, differentiating their medical devices with our coating technology, and through the Bactiguard Infection Protection (BIP) product portfolio. BIP includes coated medical devices such as catheters and trauma implants, and wound care products and sutures.
Bactiguard is headquartered in Stockholm, has production in Sweden and Malaysia, and in total around 210 employees. Listed on Nasdaq Stockholm, the company reported revenues of 253.5 MSEK in 2022.
Read more on www.bactiguard.com
Follow Bactiguard on LinkedIn